Form 4: HealthStream EVP O'Hara Reports Share Vesting & Tax Sale
Insider Transaction Report
HealthStream's Executive Vice President, Kevin P. O'Hara, reported the vesting of restricted share units and subsequent sale of shares for tax obligations.
Summary
- Kevin P. O'Hara, Executive Vice President of HealthStream Inc. (HSTM), reported transactions involving company common stock.
- Acquired 5,672 shares of common stock on March 30, 2026, through the vesting of restricted share units at a price of $0 per share.
- Disposed of 1,382 shares of common stock on March 30, 2026, at a price of $21.25 per share to cover tax liabilities associated with the vesting.
- Following these transactions, O'Hara directly beneficially owns 23,982 shares of HealthStream common stock.
- Several tranches of Restricted Share Units (RSUs) vested on March 30, 2026, converting into common stock, including 356, 448, 686, 1,722, and 2,460 units.
- Some RSU vestings are contingent on continued service, with future vesting dates extending to March 2029.
- One tranche of RSUs (2,460 units) also required the achievement of performance criteria for the period January 1, 2025, through December 31, 2025, which was met, leading to 20% vesting on March 23, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting routine executive compensation and the achievement of performance targets, which aligns executive interests with long-term company success. The tax-related sale is a standard practice.
Positives
- The vesting of restricted share units indicates the achievement of service-based and, in one case, performance-based criteria by the executive.
- The executive continues to hold a significant number of common shares (23,982) and unvested restricted share units, aligning his interests with shareholders.
Negatives
- A portion of the vested shares (1,382 shares) was sold to cover tax liabilities, which is a common practice but reduces the executive's direct shareholding.
Future Outlook
The filing details future vesting schedules for restricted share units extending to March 2029, contingent on continued service and, for some, future performance criteria established annually by the Compensation Committee.
Industry Context
StockSavvy.ai notes that routine Form 4 filings, such as this one, are standard disclosures for executive compensation and do not typically reflect broader industry trends or competitive shifts. They primarily provide transparency into insider ownership changes.
Related Party Transactions
- The reported transactions are inherently related party transactions, involving the company's Executive Vice President acquiring shares through compensation plans.
Stakeholder Impact
- Shareholders: Provides transparency into executive compensation and ownership, indicating continued alignment of executive interests with shareholder value through long-term equity holdings.
- Employees: Reflects the company's executive compensation structure, which may influence broader employee incentive programs.
Next Steps
- Future vesting of restricted share units on various dates extending to March 19, 2029, contingent on continued service.
- Annual establishment of performance criteria by the Compensation Committee for certain RSUs.
Key Dates
| Date | Description |
|---|---|
| 2022-01-01 | Start of performance period for certain RSUs. |
| 2022-12-31 | End of performance period for certain RSUs. |
| 2023-03-23 | Vesting date for 15% of certain RSUs (performance-based) and 15% of other RSUs (service-based). |
| 2024-03-22 | Vesting date for 15% of certain RSUs (service-based). |
| 2024-03-23 | Vesting date for 20% of certain RSUs (performance-based) and 20% of other RSUs (service-based). |
| 2025-01-01 | Start of performance period for certain RSUs. |
| 2025-03-19 | Vesting date for 15% of certain RSUs (service-based). |
| 2025-03-20 | Vesting date for 15% of certain RSUs (service-based). |
| 2025-03-22 | Vesting date for 20% of certain RSUs (service-based). |
| 2025-03-23 | Vesting date for 30% of certain RSUs (service-based) and 20% of other RSUs (performance-based). |
| 2025-12-31 | End of performance period for certain RSUs, with performance criteria achieved. |
| 2026-01-01 | Start of performance period for certain RSUs. |
| 2026-03-19 | Vesting date for 15% of certain RSUs (service-based). |
| 2026-03-20 | Vesting date for 20% of certain RSUs (service-based). |
| 2026-03-22 | Vesting date for 30% of certain RSUs (service-based). |
| 2026-03-23 | Vesting date for 35% of certain RSUs (service-based) and 20% of other RSUs (performance-based). |
| 2026-03-30 | Transaction date for common stock acquisition and disposition, and RSU conversions. Also the filing date. |
| 2026-12-31 | End of performance period for certain RSUs. |
| 2027-03-19 | Vesting date for 20% of certain RSUs (service-based). |
| 2027-03-20 | Vesting date for 30% of certain RSUs (service-based). |
| 2027-03-22 | Vesting date for 35% of certain RSUs (service-based). |
| 2027-03-23 | Vesting date for 25% of certain RSUs (performance-based). |
| 2028-03-19 | Vesting date for 30% of certain RSUs (service-based). |
| 2028-03-20 | Vesting date for 35% of certain RSUs (service-based). |
| 2029-03-19 | Vesting date for 35% of certain RSUs (service-based). |
Recommendation
holdThis Form 4 filing details routine executive compensation activities, specifically the vesting of restricted share units and a subsequent tax-related sale. While it confirms the executive's continued commitment through equity ownership and the achievement of performance targets, it does not present new information that would significantly alter the company's fundamental valuation or strategic outlook. Therefore, a "hold" recommendation is appropriate, as the filing does not provide a strong catalyst for a change in investment position.
Keywords
HealthStream, HSTM, Form 4, insider trading, restricted stock units, RSU vesting, executive compensation, share ownership, Kevin O'Hara, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.